United Health Products, Inc. (UEEC) Form 10-Q — Nov 17, 2026
United Health Products reported zero revenue for the three and nine months ended September 30, 2026, with a Q3 net loss of $185,268 and a nine-month net loss of $785,250. The company disclosed substantial doubt about its ability to continue as a going concern, holding only $5,588 in cash against negative working capital of $4,244,045. Substantially all of the company's convertible notes, including $500,000 held by related parties, mature on December 31, 2026, and management states it does not have the funds to repay them.
Key figures
- Eps
- 0
- Total Debt
- 4766211
- Cash Position
- 5588
- Shares Outstanding
- 266136416
- Revenue
- 0
- Rsu shares outstanding
- 40315000
- Negative working capital
- 4244045
- Error revision adjustment
- 108521
- Notes maturing dec 31 2026
- substantially all convertible notes
- Shares available for issuance
- 36314412
- Unrecognized rsu compensation
- 18834405
- Shares issuable on notes and warrants
- 77757961
- Convertible notes related party principal
- 500000
AI analysis
Red flags7 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.